Single-Use Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

The Single-Use Bioreactors Market was valued at USD 2.30 Billion in 2024, and is expected to reach USD 4.75 Billion by 2030, rising at a CAGR of 12.85%. The market’s growth is driven by increasing research and development activities, expanding collaborations, and heightened demand for novel vaccines and therapeutics. The rise in chronic and infectious diseases, along with the growing development of monoclonal antibodies, further supports market expansion. SUBs offer a scalable and cost-efficient alternative to traditional stainless-steel systems, making them attractive for both clinical and commercial manufacturing.

For instance, in January 2022, HaemaLogiX Ltd partnered with Lonza to manufacture a clinical batch of KappaMab, a monoclonal antibody targeting kappa myeloma antigen - demonstrating the role of SUBs in advanced drug development. Additionally, the rapid adoption of biologics, government funding for biologics research, and increased focus on personalized medicine are fostering demand for SUBs across global pharmaceutical and biopharmaceutical sectors. Their benefits, including reduced contamination risk, shorter turnaround times, and minimal cleaning requirements, make them increasingly indispensable in modern bioprocessing operations.

Key Market Drivers

Surge in Biopharmaceutical Demand and Biosimilar Production

The growing demand for biopharmaceutical products - particularly monoclonal antibodies, vaccines, and biosimilars - is a major driver of the single-use bioreactors market. These biologics are increasingly used to treat chronic diseases such as cancer, diabetes, and autoimmune disorders due to their targeted therapeutic effects and lower side effect profiles. SUBs offer a flexible and efficient production solution, reducing the need for time-consuming cleaning and sterilization compared to stainless-steel systems.

Supportive regulatory environments and rising public investment in biologics research are accelerating this shift. For instance, as of March 2024, the U.S. National Institutes of Health allocated USD 47.6 billion in funding, emphasizing biologics and biosimilar development. Similarly, the European Medicines Agency approved a notable number of monoclonal antibodies in 2023. These advancements, alongside favorable government policies, are promoting the adoption of SUBs to meet the evolving demands of large-scale and cost-effective biomanufacturing.

Key Market Trends

Integration of Digital Technologies in Bioprocessing

The integration of digital tools such as IoT, AI, and machine learning into SUB platforms is revolutionizing biomanufacturing practices. These technologies enable real-time monitoring, predictive analytics, and advanced process control - enhancing efficiency, product quality, and compliance.

Referred to as Bioprocessing 4.0, this evolution is being actively supported by regulatory agencies. For example, the U.S. FDA is encouraging the adoption of advanced manufacturing technologies to boost production resilience and safety. As a result, biopharmaceutical firms are increasingly investing in digitalized SUB systems, enabling smarter, faster, and more agile production processes. This synergy between single-use bioreactor platforms and digital transformation is expected to drive sustained improvements in scalability, traceability, and operational performance in the bioprocessing sector.

Key Market Players

• ABEC, INC.
• Able Corporation & Biott Corporation
• BBI-Biotech GmbH
• Cellexus Biosystems PLC
• Celltainer Biotech BV
• Danaher Corporation
• Distek Inc.
• Eppendorf AG
• G&G Technologies, Inc.
• Getinge AB

Report Scope:

In this report, the Global Single-Use Bioreactors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Single-Use Bioreactors Market, By Product:

• Single use bioreactor systems
• Single use media bags
• Single use filtration assemblies
• Other products

Single-Use Bioreactors Market, By Type:

• Stirred tank SUB
• Wave induced SUB
• Bubble Column SUB
• Other SUB

Single-Use Bioreactors Market, By Type of Cell:

• Mammalian Cell
• Bacterial Cell
• Yeast Cell
• Other Cells

Single-Use Bioreactors Market, By Molecule:

• Monoclonal Antibodies
• Vaccines
• Gene Modified Cells
• Stem Cells
• Other molecules

Single-Use Bioreactors Market, By Application:

• Research and Development
• Bioproduction

Single-Use Bioreactors Market, By Usage:

• Lab scale production
• Pilot scale production
• Large scale production

Single-Use Bioreactors Market, By End User:

• Pharmaceutical and Biopharmaceutical companies
• CROSs & CMOS
• Academic and Research Institutes

Single-Use Bioreactors Market, By Region:

• North America
• United States
• Mexico
• Canada
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• India
• South Korea
• Japan
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Single-Use Bioreactors Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.